<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="49260">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02464943</url>
  </required_header>
  <id_info>
    <org_study_id>11-007-CA</org_study_id>
    <nct_id>NCT02464943</nct_id>
  </id_info>
  <brief_title>Zenith速 Dissection Endovascular System in the Treatment of Patients With Aortic Dissections</brief_title>
  <official_title>Zenith速 Dissection Endovascular System in the Treatment of Patients With Acute, Complicated Type B Aortic Dissections</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Cook</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Cook</source>
  <brief_summary>
    <textblock>
      The Zenith速 Dissection extended study is to collect confirmatory safety and effectiveness
      data on the Zenith速 Dissection Endovascular System in the treatment of acute, complicate
      Type B aortic dissection.
    </textblock>
  </brief_summary>
  <overall_status>Available</overall_status>
  <start_date>April 2015</start_date>
  <completion_date type="Anticipated">August 2023</completion_date>
  <primary_completion_date type="Anticipated">July 2023</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Expanded Access</study_type>
  <condition>Aortic Dissection</condition>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Endovascular Treatment (Zenith)</intervention_name>
    <description>Instead of making a large incision in the chest, the physician makes a small incision near each hip to insert, and guides the study device(s) into place in the aorta.</description>
    <other_name>Endovascular graft</other_name>
    <other_name>Endovascular stent</other_name>
    <other_name>Stent-graft</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Exclusion Criteria:

          -  &lt; 18 years of age

          -  Other medical condition(e.g., cancer, congestive heart failure) that may cause the
             patient to be non-compliant with the protocol, confound the results, or is associated
             with limited life expectancy (i.e., &lt; 2 years)

          -  Pregnant, breast-feeding, or planning on becoming pregnant within 60 months

          -  Unwilling to unable to comply with the follow-up schedule

          -  Inability or refusal to give informed consent

          -  Simultaneously participating in another investigative device or drug study. (The
             patient must have completed the primary endpoint of any previous study at least 30
             days prior to enrollment in this study)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Jing Zhou, PhD</last_name>
    <phone>800-356-9208</phone>
    <email>Jing.Zhou@CookMedical.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Joseph Lombardi, MD</last_name>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Cooper University Hospital</name>
      <address>
        <city>Camden</city>
        <state>New Jersey</state>
        <zip>08103</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Pittsburgh Medical Center</name>
      <address>
        <city>Pittsburgh</city>
        <state>Pennsylvania</state>
        <zip>15213</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Virginia Medical Center</name>
      <address>
        <city>Charlottesville</city>
        <state>Virginia</state>
        <zip>22908</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>February 2017</verification_date>
  <lastchanged_date>February 27, 2017</lastchanged_date>
  <firstreceived_date>June 3, 2015</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Aorta</keyword>
  <keyword>Thoracic</keyword>
  <keyword>Aortic dissection</keyword>
  <keyword>Type B</keyword>
  <keyword>DeBakey type III</keyword>
  <keyword>Endovascular</keyword>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
